SUKI·Ambient clinical AI — documentation, point-of-care coding and clinical Q&A (health-system and ambulatory enterprise)Private

Suki

ConvictionContext

B2B enterprise SaaS on a fixed per-clinician seat licence: reported list $299/month (Suki Compose, notes only) and $399/month (full Suki Assistant with deep EHR write-back). Third-party/reseller reported — Suki publishes no price list and enterprise deals carry undisclosed volume discounts, so the rungs are upper bounds, not contracted ASPs. A second B2B2B motion, 'Suki for Partners', licenses the speech/AI engine to vendors who embed it: athenahealth's Ambient Notes, HealthEdge GuidingCare, AvaSure, WellSky.

Revenue

Not disclosed. Canon-derived: ~$60M of 2025 US ambient revenue implied by ~10% share of a ~$600M categoryMenlo Ventures via Becker's, 21 Oct 2025) — both inputs estimates, so an order of magnitude, not a revenue line.

Rev growth

No public rate. Company proxies: usage 'tripled'in 2025 to 400+ organizations; athenaOne channel 3,400 monthly active users across 450+ practices, +50% in six months (26 Jan 2026).

Gross margin

Not disclosed. Seat-licence SaaS carrying per-encounter ASR + LLM inference COGS and four deep EHR integrationsassume under 75-85%, unverified.

Op margin

Not disclosed — presumed deeply negative$168M lifetime against Abridge's ~$1.07B ($757.5M announced plus a reported $316M April-2026 extension) and Ambience's $345M is spending to hold share.

Capex intensity

Near-zero. Asset-lightno owned data centres; compute is opex in COGS/R&D.

Valuation

n/aprivate — no market cap, no clearing price). Last primary: $70M Series D, Oct 2024, led by Hedosophia (Venrock, March Capital, Flare Capital, Breyer Capital, inHealth Ventures), post-money NOT disclosed. Secondary marks conflict — Sacra ~$500M (2025) vs ~$400M elsewhere on the same round: a negotiated mark ~22 months stale, not a price, and not inferable from the $70M raise.

The read

Where our coverage leans

Coverage leans bearish

Members only

Full financial intelligence for Suki

Earnings, margins & COGS, the income-statement breakdown, SWOT, moats & dependencies, the supplier–customer ecosystem graph, top signals & trends, and the valuation range.

Income statement & margin structure
SWOT, moats & dependency map
Supplier–customer ecosystem graph
Signals, trends & valuation range

See plans

Not financial advice — analyst work product for a qualified professional.